Back
ARS Pharmaceuticals, Inc. Vs. Centene Corp. Industry Stock Comparison
Sell
30
SPRY
ARS Pharmaceuticals, Inc.
Last Price:
$8.30
Seasonality Move:
-9.8%
Sell
25
CNC
Centene Corp.
Last Price:
$35.11
Seasonality Move:
4.46%
Sell
30
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
Is ARS Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current ARS Pharmaceuticals, Inc. [SPRY] share price is $8.30. The Score for SPRY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
SPRY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Centene Corp. (CNC)
is a Sell
Is Centene Corp. a Buy, Sell or Hold?
-
The current Centene Corp. [CNC] share price is $35.11. The Score for CNC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CNC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPRY Stock Price Chart
What is ARS Pharmaceuticals, Inc.'s stock price today?
-
The ARS Pharmaceuticals, Inc. share price today is $8.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNC Stock Price Chart
What is Centene Corp.'s stock price today?
-
The Centene Corp. share price today is $35.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SPRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 46.86 | Sell |
| Chaikin Money Flow: | 1233808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.97 - 8.97) | Sell |
| Bollinger Bands (100): | (8.32 - 10.82) | Sell |
CNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2 | Sell |
| Relative Strength Index (14 RSI): | 45.44 | Sell |
| Chaikin Money Flow: | 4279508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.31 - 41.55) | Sell |
| Bollinger Bands (100): | (35.86 - 43.98) | Sell |
SPRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.04 | Buy |
| 20-day SMA: | 8.31 | Sell |
| 50-day SMA: | 9.1 | Sell |
| 200-day SMA: | 11.46 | Sell |
| 8-day EMA: | 8.13 | Buy |
| 20-day EMA: | 8.35 | Sell |
| 50-day EMA: | 8.96 | Sell |
| 200-day EMA: | 10.6 | Sell |
CNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.11 | Buy |
| 20-day SMA: | 35.09 | Buy |
| 50-day SMA: | 39.53 | Sell |
| 200-day SMA: | 36.93 | Sell |
| 8-day EMA: | 33.72 | Buy |
| 20-day EMA: | 35.32 | Sell |
| 50-day EMA: | 38.03 | Sell |
| 200-day EMA: | 41.36 | Sell |
ARS Pharmaceuticals, Inc. Earnings Growth & SPRY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.27 per share, an increase this year of $0.26 per share, and an increase next year of $0.83 per share.
Centene Corp. Earnings Growth & CNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $2.21 per share, an increase this year of $0.96 per share, and an increase next year of $1.08 per share.
ARS Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Centene Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||